LIGHTBRIDGE Corporation — 2014 Form 10-K
Business context and reporting period. This annual report covers the fiscal year ended December 31, 2014, with 2013 as the comparable period. Lightbridge develops metallic nuclear fuel technology and provides nuclear-energy consulting. In 2014, all reported revenue came from consulting; the fuel business remained in research and development and generated no revenue.
Financial results and position
| Metric | 2014 | 2013 |
|---|---|---|
| Revenue | $1.31 million | $1.90 million |
| Gross profit / margin | $554,000 / 42.3% | $791,000 / 41.6% |
| Operating expenses | $5.37 million | $5.64 million |
| Operating loss | $4.82 million | $4.85 million |
| Net loss | $4.82 million | $4.86 million |
| Basic and diluted loss per share | $0.31 | $0.37 |
| Cash used in operating activities | $4.32 million | $3.92 million |
| Cash and cash equivalents at year end | $4.22 million | $3.67 million |
- Revenue declined about 31%, primarily because work for UAE clients ENEC and FANR decreased by approximately $0.7 million; increased Lloyd’s Register work partly offset the decline. ENEC and FANR accounted for about 81% of 2014 revenue.
- Research and development expense fell to $1.53 million from $2.03 million; general and administrative expense rose to $3.83 million from $3.62 million. Gross margin percentage was broadly stable, while the net loss narrowed only slightly.
- Year-end current assets were $5.22 million and current liabilities $654,000, for working capital of approximately $4.57 million. Restricted cash was $325,000. The company reported no debt or credit lines.
- Financing provided $4.98 million of net cash, largely from the November 2014 equity offering. The offering issued approximately 2.88 million shares and warrants for approximately 2.73 million shares; year-end common shares outstanding were 18.08 million.
- No income-tax expense was recorded; deferred tax assets were fully offset by a valuation allowance. The company reported accumulated losses of $75.9 million.
Outlook, developments, and risks
- Management estimated a cash-flow shortfall of approximately $450,000 per month and stated that available working capital would not fund operations for the next 12 months at the then-current run rate. The company expected to seek additional capital in 2015 through equity, debt, bank financing, strategic partners, or new consulting contracts; it could also cut or defer spending. Management said failure to raise capital could prevent execution of its business plan.
- Management expected approximately $3 million in fuel-technology R&D spending over the next 12–15 months. Its development plan anticipated sample fabrication in 2015–2016, irradiation testing starting in late 2016 or early 2017, initial major test results in late 2017 or early 2018, commercial-reactor lead test assemblies around 2020–2021, and potential first-reload qualification in 2023–2024. These are forward-looking estimates, not achieved milestones.
- The company signed an initial cooperation agreement with Canadian Nuclear Laboratories for fuel-sample fabrication. The revised plan called for irradiation testing in Norway and post-irradiation examination in Norway or Sweden. Management said transfer to Norway depended on renewal of the U.S.–Norway 123 Agreement; failure to renew it in time could delay the program. The Canadian research reactor’s operating life was extended only through March 2018, prompting the revised plan.
- Lightbridge obtained a key U.S. metallic-fuel patent and an Australian equivalent in 2014, and reported additional patents and applications. Its claimed fuel benefits—including reactor power increases and improved safety—remain unproven in commercial operation; further testing, regulatory approvals, fabrication capability, utility participation, and industry partners are required.
- Consulting contracts provide revenue but are generally dependent on agreed project work plans. ENEC was extended through 2015 and FANR through December 2016. Management expected potential revenue opportunities in Vietnam later in 2015, but could not determine whether or when new consulting contracts would be awarded.
- Key risks include reliance on a small number of consulting clients, the need for external funding, long development and licensing timelines, nuclear-industry and public-acceptance risks, export-control approvals, and geopolitical risks involving Russia. The company also identified low natural-gas prices and reduced nuclear-project activity as potential headwinds.
- After year end, the former CFO filed state-court and OSHA complaints alleging defamation, unpaid paid time off, and retaliation. The state complaint sought at least $1 million in compensatory damages, $1 million in punitive damages, and approximately $15,507 for paid time off; the OSHA complaint did not specify damages. The company said it considered the claims without merit and intended to defend itself.
Facts investors should verify
- Whether Lightbridge raised sufficient additional capital to fund operations and planned R&D, and the resulting dilution or financing terms.
- Whether consulting revenue diversified beyond ENEC and FANR and whether announced contracts generated material, collected revenue.
- Whether the CNL fabrication and Norway irradiation plans proceeded, including renewal of the 123 Agreement and achievement of test milestones.
- Whether the fuel technology’s performance, manufacturability, licensing pathway, and proposed commercial benefits are validated by testing and utility or fabricator commitments.
- The status and financial exposure, if any, arising from the former CFO’s complaints.